SCHEMBL22563497

SCHEMBL22563497

Cc1cc(C)nc(-c2cc(-n3c4cc(-n5c6ccccc6c6ccccc65)ccc4c4ccc(-n5c6ccccc6c6ccccc65)cc43)c(C#N)c(-n3c4cc(-n5c6ccccc6c6ccccc65)ccc4c4ccc(-n5c6ccccc6c6ccccc65)cc43)c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.34
ALDH1A1 P00352 7/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
ABCG2 Q9UNQ0 6/20 0.34
MAPT P10636 4/20 0.33
LMNA P02545 3/20 0.33
MAPK1 P28482 2/20 0.33
TSHR P16473 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP11B2 P19099 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
POLB P06746 2/20 0.32
GAA P10253 2/20 0.32
GLA P06280 1/20 0.32
XBP1 P17861 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23487618 1.00 KDM4E (0.34) KDM4EALDH1A1HPGDHSD17B10ABCG2
SCHEMBL22563684 0.91 PDE9A (0.35) KDM4EALDH1A1HPGDHSD17B10ABCG2
SCHEMBL19943074 0.91 KDM4E (0.33) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL19909184 0.91 ALDH1A1 (0.36) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL19913305 0.91 ALDH1A1 (0.36) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL23487668 0.90 ABCG2 (0.41) KDM4EALDH1A1HPGDHSD17B10ABCG2
SCHEMBL23487617 0.89 KDM4E (0.38) KDM4EALDH1A1HPGDHSD17B10ABCG2
SCHEMBL23487778 0.88 PDE9A (0.38) KDM4EALDH1A1HPGDHSD17B10ABCG2
SCHEMBL22563683 0.88 ALDH1A1 (0.33) KDM4EALDH1A1HPGDHSD17B10ABCG2
SCHEMBL22563680 0.88 ABCG2 (0.39) KDM4EALDH1A1HPGDHSD17B10ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 KDM4E 4619/4885ALDH1A1 80/4885HPGD 1547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.